Patient Capital Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001854794

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Samantha McLemore — tracked via quarterly SEC 13F filings · All famous investors

MidHigh Turnover how tags are computed

Q3 2026 · 39 positions · Total reported value $2.96B · Top-10 concentration 53.3% · Updated 2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

Turnover: 69.0% · 3 new · 23 cut · 3 exited

Active Share (vs S&P 500): 80.6% · vs QQQ: 81.3% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +3.9% · vs SPY +1.8% · Prev Value $2.99B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -0.4% · vs SPY -2.6% · Latest Value $2.96B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Patient Capital Management, LLC disclosed 39 equity positions with a combined reported value of $2.96B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 53.3% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.

The largest disclosed positions as of Q3 2026 were RPRX ($199.71M), C ($179.92M), GOOGL ($178.40M). By sector, the heaviest allocations are Consumer Discretionary 24.6%, Technology 22.5%. Versus the prior quarter, allocation shifted toward Technology (+5.0pp), Financials (+1.9pp) and away from Other (-0.9pp), Health Care (-1.2pp).

Versus the prior quarter, Patient Capital Management, LLC opened 3 new positions, trimmed 23 and fully exited 3, a turnover rate of 69.0% of positions. The portfolio's overlap with the prior quarter was 86% of names.

The largest new positions opened in Q3 2026 were AVGO ($83.74M), IDRV ($271.79K), XHB ($260.12K).

Of the 3 positions fully exited versus the prior quarter, the largest were ILMN ($60.72M), PLAY ($2.33M), SPY ($791.60K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • AVGO BROADCOM INC · $83.74M
  • IDRV ISHARES TR · $271.79K
  • XHB SPDR SERIES TRUST · $260.12K

Fully Exited (vs previous quarter)

  • ILMN ILLUMINA INC · prev qtr: $60.72M
  • PLAY DAVE & BUSTERS ENTMT INC · prev qtr: $2.33M
  • SPY STATE STR SPDR S&P 500 ETF T · prev qtr: $791.60K

Insider Transactions (Form 4)

Latest Samantha McLemore buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Patient Capital Management, LLC is an SEC-registered 13F filer based in Baltimore, MD, United States. As of Q2 2026 it reported 39 US equity positions with a combined value of $2.99B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BALTIMORE, MD, United States
  • SEC registration: 801-118170 (status: Approved), registered 2020-03-05
  • Regulatory AUM (Form ADV): $2.50B as of 2026-03-27
  • Client mix (by RAUM): registered investment companies 85%, pension and profit-sharing plans 9%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: patientcapitalmanagement.com

Portfolio Structure

  • 39 positions · $2.99B reported value (Q2 2026)
  • Top 10 holdings = 52.4% of reported value
  • Largest position: RPRX (ROYALTY PHARMA PLC) at 6.8%
  • Average position size: $76.65M

Sector Tilt

  • Consumer Discretionary 28.4%
  • Health Care 19.9%
  • Financials 17.9%
  • (classified holdings cover 96% of value)

Quarterly Activity

  • Q2 2026: 2 new, 10 added, 18 reduced, 2 exited
  • 9 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund reduced exposure across 7 of its top-10 holdings (notably Financials, Health Care, and large-cap Tech), while adding to 2 smaller positions (QXO, CHYM) and holding NVDA/META. This suggests a cautious tilt toward smaller-cap, high-growth names (QXO +53% shares) and fintech (CHYM +15.9%) amid broader trimming of blue chips. 2. Key moves: - Reduced: RPRX (flat weight, -4.9% shares), C (-1.0% shares), GOOGL (-1.4% shares), AMZN (-0.6% shares), UNH (-2.7% shares), PGEN (-5.7% shares). - Added: QXO (+53.2% shares), CHYM (+15.9% shares). - Held: NVDA (flat shares), META (+0.4% shares). 3. Portfolio structure: Active (evident from targeted rebalancing), with bias toward Health Care (3 top-10 holdings) and Technology (3 top-10), but reduced exposure to mega-cap Tech/Financials. Risk appetite leans toward mid-cap growth (QXO, CHYM) over large-cap stability. 4. Per-holding one-liner: - RPRX: Royalty Pharma (biopharma royalties) - C: Citigroup (global bank) - GOOGL: Alphabet (search/tech) - AMZN: Amazon (e-commerce/cloud) - NVDA: NVIDIA (semiconductors) - UNH: UnitedHealth (health insurer) - PGEN: Precigen (gene therapy) - QXO: QXO (unverified, likely fintech/tech) - CHYM: Chime (neobank) - META: Meta (social media) 5. Style summary: Cautious rotation from large-cap blue chips to high-growth mid-caps, with selective cuts in Health Care/Tech and additions in fintech.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-14 15:21

Sector Allocation

Technology 22.5%
Financials 19.8%
Health Care 18.7%
Utilities 4.0%
Energy 3.1%
Other 4.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 3.42M $199.71M 6.75%
6.75%
Reduce
2 1.39M $179.92M 6.08%
6.08%
Reduce
3 518.48K $178.40M 6.03%
6.03%
Reduce
4 677.12K $168.70M 5.70%
5.70%
Reduce
5 709.93K $162.13M 5.48%
5.48%
Hold
6 425.85K $156.32M 5.28%
5.28%
Reduce
7 17.95M $153.65M 5.19%
5.19%
Reduce
8 10.93M $127.80M 4.32%
4.32%
Add
9 4.73M $126.03M 4.26%
4.26%
Add
10 171.50K $124.37M 4.20%
4.20%
Hold
11 6.03M $119.27M 4.03%
4.03%
Reduce
12 400.41K $96.08M 3.25%
3.25%
Add
13 1.22M $88.83M 3.00%
3.00%
Hold
14 5.97M $87.56M 2.96%
2.96%
Reduce
15 461.57K $86.04M 2.91%
2.91%
Hold
16 730.95K $85.75M 2.90%
2.90%
Reduce
17 1.90M $84.96M 2.87%
2.87%
Reduce
18 2.00M $84.11M 2.84%
2.84%
Reduce
19 238.45K $83.74M 2.83%
2.83%
New
20 969.97K $83.12M 2.81%
2.81%
Reduce
21 716.58K $79.50M 2.69%
2.69%
Reduce
22 937.32K $76.55M 2.59%
2.59%
Reduce
23 612.72K $47.18M 1.59%
1.59%
Reduce
24 167.13K $44.02M 1.49%
1.49%
Hold
25 189.40K $42.78M 1.45%
1.45%
Hold
26 691.60K $38.31M 1.29%
1.29%
Reduce
27 704.46K $33.91M 1.15%
1.15%
Reduce
28 674.20K $30.46M 1.03%
1.03%
Reduce
29 1.49M $23.36M 0.79%
0.79%
Reduce
30 276.00K $23.04M 0.78%
0.78%
Reduce
31 254.00K $20.80M 0.70%
0.70%
Reduce
32 29.36K $9.71M 0.33%
0.33%
Hold
33 100.00K $4.17M 0.14%
0.14%
Hold
34 139.09K $3.70M 0.12%
0.12%
Reduce
35 50.00K $2.08M 0.07%
0.07%
Hold
36 212.82K $1.22M 0.04%
0.04%
Reduce
37 12.50K $999.88K 0.03%
0.03%
Hold
38 8.27K $271.79K 0.01%
0.01%
New
39 2.71K $260.12K 0.01%
0.01%
New

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 70% R 70% F1 70% (modelled on 2026-Q2; 7/10 hit)

Historical Backtest (11 quarters)

Avg precision 84% · recall 84% · F1 84% · avg rank error 1.9 · Top-10 turnover 16%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 90% 90% 90% EXPE · AMZN · OMF · C · GOOGL · DAL · ET · UBS · PPLI · GM AMZN · C · EXPE · OMF · DAL · GOOGL · ET · GM · META · PPLI
2024-Q2 90% 90% 90% AMZN · C · EXPE · OMF · DAL · GOOGL · ET · GM · META · PPLI AMZN · GOOGL · C · EXPE · ET · META · GM · OMF · NVDA · PPLI
2024-Q3 80% 80% 80% AMZN · GOOGL · C · EXPE · ET · NVDA · META · PPLI · GM · OMF QXO · AMZN · GOOGL · C · EXPE · PPLI · ET · META · NVDA · BABA
2024-Q4 80% 80% 80% QXO · AMZN · GOOGL · C · EXPE · PPLI · META · ET · NVDA · BABA AMZN · QXO · GOOGL · C · ET · META · EXPE · NVDA · GM · RPRX
2025-Q1 80% 80% 80% AMZN · QXO · GOOGL · C · ET · META · NVDA · GM · RPRX · EXPE AMZN · C · QXO · GOOGL · RPRX · ET · CVS · META · PPLI · GM
2025-Q2 80% 80% 80% AMZN · C · CVS · QXO · RPRX · GOOGL · ET · META · PPLI · GM QXO · AMZN · C · GOOGL · RPRX · META · NVDA · NCLH · CVS · ET
2025-Q3 90% 90% 90% QXO · AMZN · C · GOOGL · RPRX · META · NCLH · NVDA · CVS · COIN GOOGL · C · UNH · QXO · AMZN · NVDA · NCLH · RPRX · META · CVS
2025-Q4 90% 90% 90% GOOGL · UNH · C · AMZN · QXO · NVDA · NCLH · RPRX · META · CVS GOOGL · C · AMZN · RPRX · QXO · UNH · NVDA · NCLH · BIIB · CVS
2026-Q1 80% 80% 80% GOOGL · C · UNH · RPRX · AMZN · QXO · NCLH · NVDA · BIIB · CVS RPRX · C · GOOGL · AMZN · QXO · NVDA · UNH · ET · PPLI · NCLH
2026-Q2 90% 90% 90% RPRX · C · GOOGL · AMZN · QXO · NVDA · ET · UNH · PPLI · NCLH RPRX · C · GOOGL · UNH · AMZN · NVDA · CVS · NCLH · QXO · ET
2026-Q3 ★ 70% 70% 70% RPRX · C · UNH · GOOGL · AMZN · NVDA · CVS · NCLH · QXO · ET RPRX · C · GOOGL · AMZN · NVDA · UNH · PGEN · QXO · CHYM · META

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-12. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-12 Trading days31 Holdings21 Model coverage90.7%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-12, and will update as prices arrive.

Portfolio return+1.20%Buy & hold
QQQ synthetic benchmark-11.15%Liquidity weighted
Excess return+12.35%vs benchmark
Barra annualised vol18.5%Model estimate
Realised vol17.7%Annualised in window
Weighted beta1.24Raw exposure
Factor / specific risk82% / 18%Share of variance
Top-10 concentration71.2%Of reported value
Portfolio value (start = 100)78.485.091.798.3105.010-0110-2211-12Patient Capital Management, LLCQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)+1.20%Disclosed long book
QQQ synthetic benchmark-11.15%Liquidity-weighted constituents
Model universe, equal weight+2.04%Opportunity-cost reference
Excess return+12.35%Portfolio − benchmark
Arithmetic return sum+1.38%Difference vs compounded is the cross term
Weighted raw beta1.24Weighted holding betas
Realised volatility (annualised)17.75%Daily returns in window
Barra model volatility (annualised)18.52%Factor + specific
Factor share of variance81.9%Barra factors
Specific share of variance18.1%Stock residuals
Reported value$1.92B13F long US equity

2. Return attribution

The +1.38% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 -3.29% -238.6%
Momentum & Growth 3 +0.68% 49.5%
Volatility & Tail Risk 7 -0.91% -66.0%
Industry 12 +3.26% 236.0%
Specific 1 +1.64% 119.1%
Return attribution (style + industry, %)-2.5-1.2+0.0+1.2+2.5Growth+0.35Energy+0.44Consumer Staples+0.63Information Technology-0.73Health Care+0.77Turnover-0.91Leverage (Downside Vol)+0.92Residual Volatility-0.95Historical Volatility-0.99Size-1.22Mid Cap-1.50Skewness-1.79Consumer Discretionary+2.17Beta+2.29
Factor Type Exposure Factor return Contribution Share of |return|
Beta Style +0.47 +4.92% +2.29% 166.2%
Consumer Discretionary Industry +0.23 +9.36% +2.17% 157.5%
Specific Specific — — +1.64% 119.1%
Leverage (Downside Vol) Style -0.30 -3.05% +0.92% 66.8%
Health Care Industry +0.08 +9.47% +0.77% 55.9%
Consumer Staples Industry +0.04 +14.46% +0.63% 45.4%
Energy Industry +0.04 +9.91% +0.44% 31.8%
Growth Style +0.23 +1.50% +0.35% 25.2%
Momentum Style -0.09 -3.32% +0.31% 22.6%
Amihud Illiquidity Style +0.98 +0.30% +0.29% 21.3%
Industrials Industry +0.02 +3.55% +0.09% 6.3%
Non-linear Size Style +0.99 +0.07% +0.07% 4.9%
Max Drawdown Style +0.07 -1.01% -0.08% -5.5%
Financials Industry +0.23 -0.49% -0.11% -8.0%
Kurtosis Style -0.05 +6.17% -0.32% -23.2%
Information Technology Industry +0.35 -2.11% -0.73% -53.0%
Turnover Style +0.21 -4.35% -0.91% -66.0%
Residual Volatility Style -0.44 +2.15% -0.95% -68.9%
Historical Volatility Style +0.10 -9.82% -0.99% -71.8%
Size Style +0.64 -1.93% -1.22% -88.7%
Mid Cap Style +0.78 -1.92% -1.50% -108.7%
Skewness Style +0.37 -4.77% -1.79% -129.5%

3. Risk attribution

Annualised volatility is 18.52%; factor risk explains 81.9% of variance and specific risk 18.1%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-21.3-10.7+0.0+10.7+21.3Size-1.76Amihud Illiquidity-1.32Industrials+1.51Historical Volatility+2.07Consumer Staples+2.23Leverage (Downside Vol)+2.47Non-linear Size+2.71Health Care+3.58Mid Cap+6.35Consumer Discretionary+11.67Financials+14.03Specific+18.12Beta+18.87Information Technology+19.74
Factor Type Exposure Share of variance Vol contribution Share of vol
Information Technology Industry +0.35 19.7% +3.66% 3.7%
Beta Style +0.47 18.9% +3.50% 3.5%
Specific Specific — 18.1% +3.36% 3.4%
Financials Industry +0.23 14.0% +2.60% 2.6%
Consumer Discretionary Industry +0.23 11.7% +2.16% 2.2%
Mid Cap Style +0.78 6.3% +1.18% 1.2%
Health Care Industry +0.08 3.6% +0.66% 0.7%
Non-linear Size Style +0.99 2.7% +0.50% 0.5%
Leverage (Downside Vol) Style -0.30 2.5% +0.46% 0.5%
Consumer Staples Industry +0.04 2.2% +0.41% 0.4%
Historical Volatility Style +0.10 2.1% +0.38% 0.4%
Industrials Industry +0.02 1.5% +0.28% 0.3%
Turnover Style +0.21 0.6% +0.11% 0.1%
Growth Style +0.23 0.5% +0.09% 0.1%
Energy Industry +0.04 0.3% +0.06% 0.1%
Momentum Style -0.09 0.3% +0.06% 0.1%
Liquidity Style +0.09 0.2% +0.04% 0.0%
Kurtosis Style -0.05 0.2% +0.04% 0.0%
Residual Volatility Style -0.44 -1.0% -0.19% -0.2%
Skewness Style +0.37 -1.2% -0.22% -0.2%
Amihud Illiquidity Style +0.98 -1.3% -0.24% -0.2%
Size Style +0.64 -1.8% -0.33% -0.3%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-0.9-0.10.71.62.4Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size +0.64 +2.10 -1.46
Non-linear Size +0.99 +1.68 -0.69
Mid Cap +0.78 +0.13 +0.66
Beta +0.47 +1.29 -0.83
Momentum -0.09 +0.72 -0.81
Short-term Reversal +0.02 -0.64 +0.66
Residual Volatility -0.44 -0.40 -0.04
Historical Volatility +0.10 +0.86 -0.76
Liquidity +0.09 +0.11 -0.02
Amihud Illiquidity +0.98 +1.16 -0.18
Turnover +0.21 +0.21 +0.00
Growth +0.23 +0.58 -0.35
Leverage (Downside Vol) -0.30 +0.14 -0.45
Skewness +0.37 +0.24 +0.14
Kurtosis -0.05 +0.21 -0.27
Max Drawdown +0.07 -0.08 +0.16

5. Industry allocation & Brinson

Industry allocation (weight, %)-7.414.736.858.981.0Communication ServicesUtilitiesIndustrialsConsumer StaplesEnergyHealth CareFinancialsConsumer DiscretionaryInformation TechnologyPortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 34.7% 73.6% -12.71% -16.67% +2.44% +2.92% -1.54% +7.86%
Consumer Discretionary 23.2% 8.8% +19.60% +5.93% +2.35% +1.21% +1.97% +4.03%
Health Care 8.2% 1.7% +9.77% +9.50% +1.28% +0.00% +0.02% +0.63%
Communication Services 0.0% 2.6% +0.00% -12.15% +0.05% +0.32% -0.32% +0.32%
Financials 22.7% 0.0% +0.30% +0.00% +2.36% +0.00% +0.07% +0.07%
Consumer Staples 4.3% 0.8% +4.47% +15.33% +0.90% -0.09% -0.38% +0.07%
Energy 4.4% 0.1% -0.81% -1.54% +0.38% +0.00% +0.03% -0.03%
Utilities 0.0% 0.8% +0.00% +10.14% -0.16% -0.08% +0.08% -0.08%
Industrials 2.5% 11.1% +15.45% +7.87% -1.58% +0.84% -0.66% -0.49%
Total +7.94% +5.08% -0.69% +12.33%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
C CITIGROUP INC Financials 9.38% -4.07% -0.38% Reduce
GOOGL ALPHABET INC Information Technology 9.30% -14.71% -1.37% Reduce
AMZN AMAZON COM INC Consumer Discretionary 8.80% +6.83% +0.60% Reduce
NVDA NVIDIA CORPORATION Information Technology 8.45% -23.93% -2.02% Hold
UNH UNITEDHEALTH GROUP INC Health Care 8.15% +9.77% +0.80% Reduce
CHYM CHIME FINL INC Financials 6.57% +24.17% +1.59% Add
META META PLATFORMS INC Information Technology 6.48% -13.30% -0.86% Hold
ADBE ADOBE INC Information Technology 5.01% -0.97% -0.05% Add
NCLH NORWEGIAN CRUISE LINE HLDGS Consumer Discretionary 4.57% +28.38% +1.29% Reduce
COIN COINBASE GLOBAL INC Financials 4.49% -26.90% -1.21% Hold
CROX CROCS INC Consumer Discretionary 4.47% +36.37% +1.63% Reduce
SDRL SEADRILL LTD Energy 4.43% -0.81% -0.04% Reduce
AVGO BROADCOM INC Information Technology 4.37% -1.70% -0.07% New
CVS CVS HEALTH CORP Consumer Staples 4.33% +4.47% +0.19% Reduce
GPN GLOBAL PMTS INC Consumer Discretionary 3.99% +22.73% +0.91% Reduce
GM GENERAL MTRS CO Industrials 2.46% +15.46% +0.38% Reduce
UBS UBS GROUP AG Financials 1.77% +2.60% +0.05% Reduce
DAL DELTA AIR LINES INC Consumer Discretionary 1.20% +9.42% +0.11% Reduce
TEM TEMPUS AI INC Information Technology 1.08% -3.02% -0.03% Reduce
JPM JPMORGAN CHASE & CO Financials 0.51% +4.31% +0.02% Hold
Contribution rank Symbol Sector Weight Return Contribution
1 CROX Consumer Discretionary 4.47% +36.37% +1.63%
2 CHYM Financials 6.57% +24.17% +1.59%
3 NCLH Consumer Discretionary 4.57% +28.38% +1.29%
4 GPN Consumer Discretionary 3.99% +22.73% +0.91%
5 UNH Health Care 8.15% +9.77% +0.80%
6 AMZN Consumer Discretionary 8.80% +6.83% +0.60%
7 GM Industrials 2.46% +15.46% +0.38%
8 CVS Consumer Staples 4.33% +4.47% +0.19%
9 C Financials 9.38% -4.07% -0.38%
10 META Information Technology 6.48% -13.30% -0.86%
11 COIN Financials 4.49% -26.90% -1.21%
12 GOOGL Information Technology 9.30% -14.71% -1.37%
13 NVDA Information Technology 8.45% -23.93% -2.02%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-12 (31 trading days), the reported portfolio returned +1.20%, versus -11.15% for the QQQ synthetic benchmark — an excess of +12.35%.
  2. Return attribution: the largest positive style/industry contributions came from Beta +2.29%, Consumer Discretionary +2.17%, Leverage (Downside Vol) +0.92%; the largest drags came from Skewness -1.79%, Mid Cap -1.50%, Size -1.22%. Specific (stock-level) return contributed +1.64%.
  3. Risk attribution: Barra model volatility is 18.52% annualised; factor risk explains 82% of variance and specific risk 18%. The largest factor risk sources are Information Technology 19.7%, Beta 18.9%, Financials 14.0%.
  4. Style tilt: size +0.64, momentum -0.09, volatility +0.10, liquidity +0.09; the weighted raw beta is 1.24. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Financials (+22.7 pp), the largest underweight is Information Technology (-38.9 pp). Allocation contributed +7.94%, selection +5.08% and interaction -0.69%.
  6. Concentration: the top-10 positions are 71.2% of the attributed portfolio and the model covers 90.7% of its value with full style exposures; the remainder is mapped to its sector only. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Patient Capital Management, LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, Patient Capital Management, LLC reported 39 equity positions worth $2.96B in aggregate; its largest disclosed positions were RPRX ($199.71M), C ($179.92M), GOOGL ($178.40M).

How large is Patient Capital Management, LLC's portfolio?

Patient Capital Management, LLC reported $2.96B of long equity holdings across 39 positions as of 2026-Q3. Top-10 holdings account for 53.3% of reported value.

What is Patient Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/patient-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →